Baotou Dongbao Bio-tech News

Dongbao Biotech (300239): Gelatin and by-products business grew steadily, Yiqing Biotech added a new capsule production capacity of 15 billion capsules/year

Apr 26 00:00

Dongbao Biotech (300239): Net profit from mother in the first three quarters increased by +9% compared to the same period, gross margin increased by nearly 1PCT

Nov 6, 2023 00:00

Dongbao Biotech (300239): 23H1 Gimu's net profit was +12.12% year-on-year, continuing to promote industrial chain integration

長城證券Aug 31, 2023 00:00

Dongbao Biotech (300239): Net profit increased significantly by +31% compared to the same period in Q1

長城證券Apr 26, 2023 00:00

Dongbao Biotech (300239): Guimu's net profit is +200% year-on-year, expanding new fields of application of gelatin and collagen products

長城證券Mar 22, 2023 00:00

Toho Biotech (300239): Profitability continues to improve, Q3 returns net profit increased 381%

長城證券Oct 27, 2022 00:00

Dongbao Biotech (300239): The company's operating efficiency increased significantly, 22H1 net profit increased 668%, gross margin increased 14PCT

長城證券Aug 29, 2022 00:00

Dongbao Biotech (300239) Company Dynamic Review: Return to Mother's Net Profit Increased 98% Year-on-Year in '21 to Build a Leading Domestic Collagen Brand

長城證券Apr 27, 2022 00:00

Dongbao Bio (300239): 21 years' net profit growth of 93%. Profitability rebounded significantly.

長城證券Mar 24, 2022 00:00

Dongbao Bio (300239): forecast full-year return net profit 3000-40 million profitability rebounded significantly

長城證券Jan 5, 2022 00:00

Dongbao Biological (300239): equity incentive plan brings together people, new production capacity, new products and new growth.

太平洋證券May 25, 2018 00:00

Dongbao Biotech (300239): After implementing the employee stock ownership plan, graduation records reached an inflection point this year

中信建投Feb 19, 2016 00:00

[Changjiang Securities] Dongbao Biology: aim high, "Yuansu" is worth looking forward to

長江證券Dec 10, 2014 00:00

Dongbao Biological (300239) performance Forecast comment: raise the price of gelatin in full production of the fund-raising project

日信證券Apr 10, 2013 00:00

[Rixin Securities] Dongbao Bio: the fund-raising project has been fully put into production, and the price of gelatin has increased.

日信證券Apr 9, 2013 00:00

[Rixin Securities] Dongbao Biological Review: the degree of industry integration is high, and the performance will be gradually improved.

日信證券May 17, 2012 00:00

[Shanghai Securities] Dongbao Biological depth report: the prosperity of gelatin business is improving, and there are many bright spots of collagen.

上海證券Apr 23, 2012 00:00

[Rixin Securities] Dongbao Bio: the performance is in line with expectations, waiting for the collagen breakthrough.

日信證券Mar 26, 2012 00:00

[Nippon Securities] Dongbao Bio: performance meets expectations, collagen improves performance

日信證券Jan 20, 2012 00:00

【日信证券】东宝生物调研简报:明胶稳定增长,胶原蛋白蓄势待发

日信證券Dec 27, 2011 00:00